Acute oxalate nephropathy associated with orlistat
Background: Obesity is a major world-wide epidemic which has led to a surge of various weight loss-inducing medical or surgical treatments. Orlistat is a gastrointestinal lipase inhibitor used as an adjunct treatment of obesity and type 2 diabetes mellitus to induce clinically significant weight los...
Saved in:
Main Authors: | , , , , |
---|---|
格式: | 圖書 |
出版: |
Society of Diabetic Nephropathy Prevention,
2016-04-01T00:00:00Z.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!